Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ovarian Neoplasms

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    March 2019
  1. SOOKRAM J, Zheng A, Linden KM, Morgan AB, et al
    Epigenetic therapy can inhibit growth of ovarian cancer cells and reverse chemoresistant properties acquired from metastatic omentum.
    Int J Gynaecol Obstet. 2019 Mar 3. doi: 10.1002/ijgo.12800.
    PubMed     Text format     Abstract available


    January 2019
  2. DITTO A, Leone Roberti Maggiore U, Bogani G, Martinelli F, et al
    Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2019 Jan 30. doi: 10.1002/ijgo.12769.
    PubMed     Text format     Abstract available


    November 2018
  3. LEE DY, Kim HJ, Lee JY, Choi D, et al
    Usefulness of repeat pelvic ultrasonography before surgery for benign ovarian mass.
    Int J Gynaecol Obstet. 2018 Nov 8. doi: 10.1002/ijgo.12708.
    PubMed     Text format     Abstract available


    October 2018
  4. BEREK JS, Kehoe ST, Kumar L, Friedlander M, et al
    Cancer of the ovary, fallopian tube, and peritoneum.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:59-78.
    PubMed     Text format     Abstract available


  5. BASU P, Mukhopadhyay A, Konishi I
    Targeted therapy for gynecologic cancers: Toward the era of precision medicine.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:131-136.
    PubMed     Text format     Abstract available


    September 2018
  6. BOGANI G, Leone Roberti Maggiore U, Chiappa V, Ditto A, et al
    The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2018 Sep 8. doi: 10.1002/ijgo.12667.
    PubMed     Text format     Abstract available


    August 2018
  7. LEE YY, Lee JW, Lu L, Xu W, et al
    Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2018 Aug 20. doi: 10.1002/ijgo.12653.
    PubMed     Text format     Abstract available


  8. ZHU F, Xu X, Shi B, Zeng L, et al
    The positive predictive value of low-density lipoprotein for recurrence-free survival in ovarian cancer.
    Int J Gynaecol Obstet. 2018 Aug 15. doi: 10.1002/ijgo.12645.
    PubMed     Text format     Abstract available


    May 2018
  9. MICHAAN N, Gortzak-Uzan L, Grisario D, Laskov I, et al
    Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.
    Int J Gynaecol Obstet. 2018 May 9. doi: 10.1002/ijgo.12524.
    PubMed     Text format     Abstract available


    January 2018
  10. SHENG X, Zhong Y, Lu C, Peng J, et al
    Clinical study of hereditary ovarian cancer syndrome in Shandong province, East China.
    Int J Gynaecol Obstet. 2018 Jan 23. doi: 10.1002/ijgo.12447.
    PubMed     Text format     Abstract available


    November 2017
  11. MAY T, Stewart JM, Bernardini MQ, Ferguson SE, et al
    The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer.
    Int J Gynaecol Obstet. 2017 Nov 2. doi: 10.1002/ijgo.12376.
    PubMed     Text format     Abstract available


    October 2017
  12. MINAR L, Felsinger M, Cermakova Z, Zlamal F, et al
    Comparison of the Copenhagen Index versus ROMA for the preoperative assessment of women with ovarian tumors.
    Int J Gynaecol Obstet. 2017 Oct 31. doi: 10.1002/ijgo.12371.
    PubMed     Text format     Abstract available


    August 2017
  13. SON JH, Kong TW, Paek J, Song KH, et al
    Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2017 Aug 31. doi: 10.1002/ijgo.12315.
    PubMed     Text format     Abstract available


    May 2017
  14. KAPP DS, Rosenfeld EB, Chan JE, Chan JK, et al
    Factors associated with oophorectomy in children with benign ovarian masses.
    Int J Gynaecol Obstet. 2017 May 28. doi: 10.1002/ijgo.12223.
    PubMed     Text format     Abstract available


  15. LIU R, Cheng J, Chen Y, Wang W, et al
    Potential role and prognostic importance of dishevelled-2 in epithelial ovarian cancer.
    Int J Gynaecol Obstet. 2017 May 17. doi: 10.1002/ijgo.12218.
    PubMed     Text format     Abstract available


    March 2017
  16. ZHANG T, Li F, Liu J, Zhang S, et al
    Diagnostic performance of the Gynecology Imaging Reporting and Data System for malignant adnexal masses.
    Int J Gynaecol Obstet. 2017 Mar 13. doi: 10.1002/ijgo.12153.
    PubMed     Text format     Abstract available


    February 2017
  17. HILLMAN RT, Saenz CC, McHale MT, Plaxe SC, et al
    Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12109.
    PubMed     Text format     Abstract available


    January 2017
  18. BATTARBEE A, Strohl A, Zimmerman L, Patel A, et al
    Applicability of the modified ACOG/SGO referral criteria for adnexal mass within a limited-resource setting.
    Int J Gynaecol Obstet. 2017;136:53-57.
    PubMed     Text format     Abstract available


    June 2016
  19. KIM ML, Cho YJ, Kim MK, Jung YW, et al
    The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
    Int J Gynaecol Obstet. 2016 Jun 4. pii: S0020-7292(16)30164.
    PubMed     Text format     Abstract available


  20. LIAN C, Chen X, Ni Y, Huang X, et al
    Pregnancy after fertility-sparing surgery for borderline ovarian tumors.
    Int J Gynaecol Obstet. 2016 Jun 3. pii: S0020-7292(16)30165.
    PubMed     Text format     Abstract available


    March 2016
  21. PARK JY, Suh DS, Kim JH, Kim YM, et al
    Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.
    Int J Gynaecol Obstet. 2016 Mar 11. pii: S0020-7292(16)30006.
    PubMed     Text format     Abstract available


    February 2016
  22. VAN DEN AKKER PA, Zusterzeel PL, Aalders AL, Snijders MP, et al
    Use of risk of malignancy index to indicate frozen section analysis in the surgical care of women with ovarian tumors.
    Int J Gynaecol Obstet. 2016 Feb 24. pii: S0020-7292(16)00097.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: